SGLT2i in Diabetic Patients with Renal Transplantation
NCT06731231
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
72
Enrollment
OTHER
Sponsor class
Conditions
Post-transplant Diabetes Mellitus
Interventions
DRUG:
SGLT2 inhibitor
Sponsor
Ain Shams University